- Investing Ideas
- /
- French Pharmaceuticals & Biotech Potentially Undervalued Companies
French Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
14
0 new
Companies with a Value score of at least 3, ordered by Value score
14 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ALONC | €14.42 | 0% | 57.3% | €99.4m | €18.64 | PS3x | E101.2% | n/a | ||
VETO | €72.90 | -1.2% | -27.5% | €862.6m | €93.43 | PE18.3x | E7.5% | 1.2% | ||
VIRP | €305.00 | -3.8% | -13.0% | €2.6b | €396.94 | PE18.1x | E10.4% | 0.4% | ||
EAPI | €2.81 | -0.8% | -58.4% | €267.9m | €3.38 | PS0.3x | E66.1% | n/a | ||
MEDCL | €13.50 | -7.2% | 49.8% | €401.7m | €22.23 | PS30.4x | E114.3% | n/a | ||
ERF | €49.44 | -2.1% | -14.0% | €9.3b | €58.39 | PE26.1x | E18.5% | 1.2% | ||
ALTHX | €0.53 | 2.3% | -28.9% | €4.1m | €6.20 | PS1.8x | E112.8% | n/a | ||
BOI | €24.95 | -0.6% | -30.7% | €433.2m | €33.30 | PE18.3x | E26.2% | 5.4% | ||
VLA | €3.78 | 2.1% | 12.4% | €613.1m | €6.69 | PS3.9x | E-13.6% | n/a | ||
AELIS | €1.98 | -8.3% | -85.3% | €27.0m | €9.10 | PS2.5x | E33.8% | n/a | ||
SAN | €103.58 | -1.7% | 16.7% | €129.8b | €116.85 | PE23.6x | E13.4% | 3.8% | ||
GNFT | €3.65 | -6.4% | 8.1% | €182.0m | €9.45 | PE8.2x | E45.2% | n/a | ||
IPH | €2.10 | 9.6% | -10.6% | €176.0m | €6.14 | PS5.2x | E50.9% | n/a | ||
NANO | €3.62 | -8.5% | -42.1% | €171.4m | €11.17 | PS4.1x | E36.5% | n/a |
Page 1 of 1